The community prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in older people living in their own homes: implications for treatment, screening and surveillance in the UK

The Journal of Hospital Infection
J MaudsleyP G Wallace

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) predominantly affects those over 65 years old. There may be a substantial pool of older people with MRSA in the community. We studied the prevalence in one London general practice, screening 258 older people living in their own home. MRSA (E-MRSA 15) was found in two participants (0.78%). Past history of MRSA was the only significant risk factor. The results of this and other studies suggest that national guidelines recommending early discharge for MRSA carriers have not resulted in widespread community acquisition amongst elderly people living in their own home. Community antibiotic policies for skin and soft-tissue infection do not require amendment. Patients with previous MRSA should be isolated and screened on admission especially to high-risk units.

References

Mar 9, 2000·The Journal of Hospital Infection·M MorganA Howard
Jul 6, 2000·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·B D Cookson
Jul 27, 2001·Epidemiology and Infection·L AbuduK K Cheng
Sep 14, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Philippe DufourHervé Richet
Jan 11, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Cassandra D SalgadoDavid P Calfee

❮ Previous
Next ❯

Citations

Nov 16, 2010·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Wei-Ting ChenShan-Chwen Chang
Apr 3, 2010·British Medical Bulletin·Fiona J Cooke, Nicholas M Brown
Oct 29, 2005·BMJ : British Medical Journal·Georgia Duckworth, Andr Charlett
Sep 13, 2005·BMJ : British Medical Journal·David H WyllieDerrick Crook
Jan 25, 2008·Emerging Infectious Diseases·Verena Schneider-LindnerSamy Suissa
Aug 1, 2010·Toxins·Irina V PinchukVictor E Reyes
Mar 1, 2008·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Sarah Smyth
Feb 4, 2006·The Journal of Hospital Infection·J A KarasM M Emery
Feb 26, 2016·Journal of Clinical Orthopaedics and Trauma·Sanjay AgarwalaAnshul Sobti
Aug 14, 2008·The Surgeon : Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland·K HassanS Giles
Jul 15, 2009·The Journal of Hospital Infection·D RathodI K Hosein
Aug 16, 2006·Seminars in Cutaneous Medicine and Surgery·Monica HalemFrancisco Kerdel
Mar 18, 2006·The Journal of Hospital Infection·J-U S JensenL P Andersen
Dec 12, 2012·Journal of Medical Microbiology·Jenny GamblinStuart C Clarke
Jan 17, 2009·FEMS Microbiology Letters·Diana LeeDerren Ready
Sep 16, 2008·Irish Journal of Medical Science·L Power, J Brophy
Dec 9, 2009·The British Journal of Developmental Psychology·Kevin DurkinZoë Simkin
Sep 6, 2005·The Journal of Antimicrobial Chemotherapy·Anette LoefflerDavid H Lloyd
May 25, 2006·The Journal of Bone and Joint Surgery. British Volume·S J RocheJ P McCabe
May 25, 2006·The Journal of Bone and Joint Surgery. British Volume·M NixonG Taylor
Jun 26, 2017·Psychologica Belgica·Katrien SymonsWannes Heirman
Oct 26, 2007·Annals of the Royal College of Surgeons of England·K HassanS N Giles
Apr 1, 2010·Journal of Clinical Pathology·W S A SmellieR Bowley
Apr 4, 2019·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·Simon PackerMaya Gobin
Mar 2, 2011·The American Journal of Geriatric Pharmacotherapy·Troy D KishHoratio B Fung

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.